Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

Sentreheart, Lariat Surgical LAA Suture Delivery Device, left atrial appendage closure, CE Mark approval, Europe

Image courtesy of SentreHeart

News | Left Atrial Appendage (LAA) Occluders | October 28, 2015
October 28, 2015 — SentreHeart Inc. announced that it has received CE Mark approval for the Lariat Surgical Left Atrial...
Praxbind, Pradaxa reversal agent, FDA approval, emergency situations
Technology | Antiplatelet and Anticoagulation Therapies | October 19, 2015
October 19, 2015 — The U.S. Food and Drug Administration (FDA) granted accelerated approval to Praxbind (idarucizumab)...
AtriCure, definitive merger agreement, nContact Inc., atrial fibrillation solutions, cardiac ablation
News | Ablation Systems | October 14, 2015
October 14, 2015 — AtriCure Inc. announced it has entered into a definitive merger agreement under which AtriCure has...
Acutus Medical, AcQMap High Resolution Imaging and Mapping System, improvement over sCT

Image courtesy of Acutus Medical

News | EP Mapping and Imaging Systems | October 06, 2015
October 6, 2015 — Acutus Medical, a global heart rhythm technology company, presented data that show the AcQMap High...
AtriCure, cryoFORM cryoablation probe, launch
Technology | Ablation Systems | October 02, 2015
October 2, 2015 — AtriCure Inc. launched the cryoFORM cryoablation probe, which offers increased probe flexibility to...
ACC, atrial fibrillation registries, ablation, left atrial appendage occlusion procedures, LAAO Registry
News | Atrial Fibrillation | September 24, 2015
September 24, 2015 — The American College of Cardiology (ACC) launched two new clinical registry programs in August to...
MedLumics, OCT, real-time assessment, catheter ablation, atrial fibrillation
Feature | EP Mapping and Imaging Systems | September 17, 2015
September 17, 2015 — MedLumics has announced the completion of a successful single-case pre-clinical feasibility study...
Texas Heart Institute, Rice University, grant, nanotubes, heart, electrical signals
Feature | EP Lab | September 14, 2015
September 14, 2015 — Texas Heart Institute (THI) announced that it has received a prestigious American Heart...
AliveCor Mobile ECG, AFib, detection, atrial fibrillation

AliveCor Mobile ECG image courtesy of AliveCor

News | ECG Monitoring Services | September 10, 2015
September 10, 2015 — AliveCor Inc. announced significant milestones related to patients with atrial fibrillation (AFib...
News | Atrial Fibrillation | September 01, 2015
September 1, 2015 — The first-ever two-year outcomes from the Global Anticoagulant Registry in the Field - Atrial...
Passive Elastography, TTP, U.K., ablation, atrial fibrillation
News | Cardiovascular Ultrasound | August 10, 2015
August 10, 2015 — The Technology Partnership (TTP), a U.K.-based research and product development company, has made...
Boehringer Ingelheim, RE-DUAL PCI, RE-CIRCUIT, Pradaxa, first U.S. patients,
News | Antiplatelet and Anticoagulation Therapies | August 05, 2015
August 5, 2015 — Boehringer Ingelheim announced the first U.S. patients have been enrolled in two of the company's...
triple therapy, dual antiplatelet therapy, atrial fibrillation, heart attack, older patients, JACC
News | Antiplatelet and Anticoagulation Therapies | August 04, 2015
August 4, 2015 — Triple therapy is no better than dual antiplatelet therapy in preventing major adverse cardiac events...
Feature | Atrial Fibrillation | July 20, 2015
July 20, 2015 - A new study proves race and gender-related disparities exist in care for patients who have recently...
sentraheart lariet, LAA occlusion, FDA safety alert
Feature | Left Atrial Appendage (LAA) Occluders | July 13, 2015
July 13, 2015 - The U.S. Food and Drug Administration (FDA) is alerting healthcare providers and patients about reports...